Behind the Scenes: Maharashtra's Journey Towards a TB-Free Future

▴ tuberculosis
The state's healthcare system faces pressing challenges, particularly the shortage of essential medicines for MDR-TB patients. Bridging this gap requires not only the establishment of training facilities but also a simultaneous commitment to addressing the fundamental issues damaging TB treatment and prevention.

In a significant stride towards eradicating tuberculosis (TB) by 2025, the State Tuberculosis Training and Demonstration Centre (STDC) in Pune has enrolled over 25 doctors from nine states. The Centre's initiative aims to develop five training centres across the country, offering a 'National Tuberculosis Trainer Training Programme.' Despite the progress, challenges such as a shortage of essential medicines and testing cartridges persist, raising concerns among health experts.

The Role of STDC: The STDC, the first and currently only facility of its kind in Maharashtra, plays a pivotal role in supporting the Revised National Tuberculosis Control Programme. Officials highlight its significance in assisting state TB officers with various program-related activities, including case identification, patient management, and program monitoring and evaluation. The comprehensive training provided by STDC is crucial for achieving the ambitious goal of eliminating TB by 2025.

Maharashtra's Challenge: While the STDC brings hope for improved training and capacity building, an official from the state health minister's office emphasizes the need for more trained healthcare staff in Maharashtra. The state requires professionals capable of early detection and treatment of TB cases to meet the Centre's target. Pune stands out as the sole centre in Maharashtra equipped with an STDC to offer such vital training programs.

Despite the positive momentum, health experts express concerns about unaddressed challenges. They applaud the establishment of training facilities but criticize the central government's oversight of a crucial issue which is the shortage of essential medicines for thousands of multi-drug resistance TB (MDR-TB) patients in Maharashtra. These patients struggle to complete their drug courses due to medication unavailability.

Call for Urgent Measures: The disparity between the government's vision for TB elimination and the ground reality is evident. Health activists stress the importance of addressing these basic issues like medicinal shortages and testing equipment deficiencies, to make meaningful progress in the fight against TB. Urgent measures are needed to ensure that the ambitious goals set by the Centre align with the practical needs and challenges faced by healthcare providers and patients on the ground.

In conclusion, as Maharashtra strives to contribute to the national goal of eliminating TB by 2025, the establishment of the STDC in Pune is a commendable step. However, the state's healthcare system faces pressing challenges, particularly the shortage of essential medicines for MDR-TB patients. Bridging this gap requires not only the establishment of training facilities but also a simultaneous commitment to addressing the fundamental issues damaging TB treatment and prevention. Through collaborative efforts and focused attention on these challenges, Maharashtra can pave the way for a more effective and inclusive approach to TB eradication

Tags : #tuberculosis #TBfree #maharashtra #lunghealth #endTB #medicircle

About the Author


Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

14 Feb

Novartis India Limited signs exclusive sales and distribution agreement with Dr. Reddy’s Laboratories

Latest corporate news update; Pharma

View
03 Feb

European Commission approves Teysuno in metastatic colorectal cancer

Latest Corporate news updates; Pharma Feb 3rd 2022

View
24 Dec

Novartis acquires a gene-therapy company Gyroscope Therapeutics

Swiss healthcare giant Novartis has agreed to pay $1.5 billion to acquire British biotech company Gyroscope Therapeutics.

View
31 Aug

ImmixBio and BeiGene to evaluate combination of IMX-110 and Tislelizumab in solid tumors

Latest Pharma News Update

View
02 Aug

GSK and Vir Biotechnology announce joint procurement agreement with European Commission for COVID-19 treatment, Sotrovimab

Latest pharma news update

View
21 Jun

Novartis receives FDA approval 177Lu-PSMA-617 for metastatic castration resistant prostate cancer

FDA breakthrough therapy for Novartis metastatic prostate cancer drug

View
08 May

Roche’s Tecentriq approved by European Commission for metastatic non-small cell lung cancer

Tecentriq is now the first and only single-agent cancer immunotherapy with three dosing options

View
25 Mar

Novartis announces positive result of phase III study with radioligand therapy 177Lu-PSMA-617

The study is aimed for patients with advanced prostate cancer

View
15 Feb

Xeris Pharmaceuticals receives approval from the European Commission for Ogluo

Ogluo (Glucagon) is indicated treatment of severe hypoglycemia

View
10 Feb

Novartis receives FDA Breakthrough Therapy designations for STAMP inhibitor asciminib (ABL001)

Novartis receives FDA Breakthrough Therapy designations for investigational STAMP inhibitor asciminib (ABL001) in chronic myeloid leukaemia

View

-Advertisements-




Trending Now

Maternal and Infant Health in Focus as India Observes World Health Day 2025April 05, 2025
Under 15 Children Under Threat: The TB Comeback No One Saw Coming April 04, 2025
MGM Healthcare Performs World's First Modified Multi-Visceral Transplant for Rare Intestinal DisorderApril 04, 2025
World Health Day 2025: St. George’s University’s Role in Preparing Doctors to Tackle Global Health ChallengesApril 04, 2025
Strength Doesn’t Retire: The Science Behind Ageless PowerApril 04, 2025
Beyond the Baby Bump: Can Delayed Pregnancy Increase Autism Risk in ChildrenApril 04, 2025
University of Manchester invites applications for MA Social AnthropologyApril 03, 2025
Ahead of World Health Day, Sova Health Launches Advanced Microbiome Tests & Evidence-Based Precision Supplements April 03, 2025
Half of women cannot make decisions about their reproductive health and bodily autonomyApril 03, 2025
UGRO CAPITAL LIMITED PUBLIC ISSUE OF SECURED, RATED, LISTED, REDEEMABLE, NON-CONVERTIBLE DEBENTURES (SECURED NCDS) OPENS TODAY EFFECTIVE ANNUALIZED YIELD UP TO 11.01% PER ANNUM* April 03, 2025
SF Airlines Entrusts Çelebi India with Freighter Handling at Kempegowda International Airport, BengaluruApril 03, 2025
Is This the Future of Physiotherapy? Inside Stance Health’s $1M ExpansionApril 03, 2025
The Daily Shower Debate: Are You Washing Away Your Skin’s Health?April 03, 2025
The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025